38 related articles for article (PubMed ID: 8557177)
1. Single-nucleotide polymorphisms in the IL2RA gene are associated with age at diagnosis in late-onset Finnish type 1 diabetes subjects.
Klinker MW; Schiller JJ; Magnuson VL; Wang T; Basken J; Veth K; Pearce KI; Kinnunen L; Harjutsalo V; Wang X; Tuomilehto J; Sarti C; Ghosh S
Immunogenetics; 2010 Feb; 62(2):101-7. PubMed ID: 20033399
[TBL] [Abstract][Full Text] [Related]
2. Full likelihood analysis of genetic risk with variable age at onset disease--combining population-based registry data and demographic information.
Pitkäniemi J; Varvio SL; Corander J; Lehti N; Partanen J; Tuomilehto-Wolf E; Tuomilehto J; Thomas A; Arjas E
PLoS One; 2009 Aug; 4(8):e6836. PubMed ID: 19718441
[TBL] [Abstract][Full Text] [Related]
3. The primacy of CD8 T lymphocytes in type 1 diabetes and implications for therapies.
Faustman DL; Davis M
J Mol Med (Berl); 2009 Dec; 87(12):1173-8. PubMed ID: 19693476
[TBL] [Abstract][Full Text] [Related]
4. Genetic susceptibility in type 1 diabetes and its associated autoimmune disorders.
Ide A; Eisenbarth GS
Rev Endocr Metab Disord; 2003 Sep; 4(3):243-53. PubMed ID: 14501175
[No Abstract] [Full Text] [Related]
5. Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to H-2K(d) that stimulates CD8 T cells in insulin-dependent diabetes mellitus.
Wong FS; Moustakas AK; Wen L; Papadopoulos GK; Janeway CA
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5551-6. PubMed ID: 11943852
[TBL] [Abstract][Full Text] [Related]
6. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene.
Lie BA; Todd JA; Pociot F; Nerup J; Akselsen HE; Joner G; Dahl-Jørgensen K; Rønningen KS; Thorsby E; Undlien DE
Am J Hum Genet; 1999 Mar; 64(3):793-800. PubMed ID: 10053014
[TBL] [Abstract][Full Text] [Related]
7. A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting.
Weinberg CR; Wilcox AJ; Lie RT
Am J Hum Genet; 1998 Apr; 62(4):969-78. PubMed ID: 9529360
[TBL] [Abstract][Full Text] [Related]
8. [HLA, A, B, C, DR, C4, Bf in insulin-dependent diabetics in the Tunisian population].
Jenhani F; Bardi R; Gorgi Y; Ayed K; Chammaki S; Boukhris R
Ann Biol Clin (Paris); 1989; 47(1):23-8. PubMed ID: 2648900
[TBL] [Abstract][Full Text] [Related]
9. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus.
Thomson G; Robinson WP; Kuhner MK; Joe S; MacDonald MJ; Gottschall JL; Barbosa J; Rich SS; Bertrams J; Baur MP
Am J Hum Genet; 1988 Dec; 43(6):799-816. PubMed ID: 3057885
[TBL] [Abstract][Full Text] [Related]
10. Variation in HLA-associated risks of childhood insulin-dependent diabetes in the Finnish population: I. Allele effects at A, B, and DR loci. DiMe Study Group. Childhood Diabetes in Finland.
Langholz B; Tuomilehto-Wolf E; Thomas D; Pitkäniemi J; Tuomilehto J
Genet Epidemiol; 1995; 12(5):441-53. PubMed ID: 8557177
[TBL] [Abstract][Full Text] [Related]
11. Variation in HLA-associated risks of childhood insulin-dependent diabetes in the Finnish population: II. Haplotype effects. DiMe Study Group. Childhood Diabetes in Finland.
Thomas D; Pitkäniemi J; Langholz B; Tuomilehto-Wolf E; Tuomilehto J
Genet Epidemiol; 1995; 12(5):455-66. PubMed ID: 8557178
[TBL] [Abstract][Full Text] [Related]
12. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.
Fennessy M; Metcalfe K; Hitman GA; Niven M; Biro PA; Tuomilehto J; Tuomilehto-Wolf E
Diabetologia; 1994 Sep; 37(9):937-44. PubMed ID: 7806025
[TBL] [Abstract][Full Text] [Related]
13. HLA and insulin gene associations with IDDM.
Thomson G; Robinson WP; Kuhner MK; Joe S; Klitz W
Genet Epidemiol; 1989; 6(1):155-60. PubMed ID: 2567257
[TBL] [Abstract][Full Text] [Related]
14. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.
Metcalfe KA; Hitman GA; Fennessy MJ; McCarthy MI; Tuomilehto J; Tuomilehto-Wolf E
Diabetologia; 1995 Oct; 38(10):1223-9. PubMed ID: 8690176
[TBL] [Abstract][Full Text] [Related]
15. HLA A, B, and DR antigens and complotype in Tunisian patients with diabetes mellitus.
Ayed K; Bardi R; Gorgi Y; Jenhani F; Chammakhi S; Boukhris R
Dis Markers; 1989; 7(1):43-7. PubMed ID: 2714046
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
